<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="article-commentary" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">107787</article-id><article-id pub-id-type="doi">10.7554/eLife.107787</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Insight</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Acute Lung Injury</subject></subj-group></article-categories><title-group><article-title>The double-edged nature of trained immunity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Leopold Wager</surname><given-names>Chrissy M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3828-055X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Chrissy M Leopold Wager</bold> is at the Host Pathogen Interactions Program, Texas Biomedical Research Institute, San Antonio, United States</p></bio></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Schlesinger</surname><given-names>Larry S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7177-8421</contrib-id><email>lschlesinger@txbiomed.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Larry S Schlesinger</bold> is at the Host Pathogen Interactions Program, Texas Biomedical Research Institute, San Antonio, United States</p></bio></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00wbskb04</institution-id><institution>Host Pathogen Interactions Program, Texas Biomedical Research Institute</institution></institution-wrap><addr-line><named-content content-type="city">San Antonio</named-content></addr-line><country>United States</country></aff></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>03</day><month>07</month><year>2025</year></pub-date><volume>14</volume><elocation-id>e107787</elocation-id><permissions><copyright-statement>© 2025, Leopold Wager and Schlesinger</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Leopold Wager and Schlesinger</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-107787-v1.pdf"/><related-article related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.7554/eLife.102068" id="ra1"/><abstract><p>Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>trained immunity</kwd><kwd>acute lung injury</kwd><kwd>beta-glucan</kwd><kwd>alveolar macrophage</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Template</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text><p><bold>Related research article</bold> Prével R, Pernet E, Tran KA, Sadek A, Sadeghi M, Lapshina E, Jurado L, Kristof AS, Moumni M, Poschmann J, Divangahi M. 2024. β-glucan reprograms alveolar macrophages via neutrophil/IFNγ axis to promote lung injury. <italic>eLife</italic> <bold>13</bold>:RP102068. doi: <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.7554/eLife.102068">10.7554/eLife.102068</ext-link>.</p></boxed-text><p>The concept of trained immunity has transformed our understanding of how the innate immune system responds to stimuli. For many years, the responses of innate immune cells – such as monocytes, macrophages, natural killer cells and neutrophils – were seen as short-lived and non-specific. However, we know now that these immune cells can adapt their responses after being exposed to a stimulus for the first time. This initial encounter trains these cells to respond more vigorously to subsequent challenges, which typically leads to increased resistance to various infections. This memory-like state is typically triggered by microbial components like β-glucan, the BCG vaccine, and certain endogenous signals (<xref ref-type="bibr" rid="bib8">Netea et al., 2020</xref>). The training that follows these exposures results in long-term changes in transcription, chromatin structure and cellular metabolism in the immune cells. However, while trained immunity is often protective, it can also carry costs.</p><p>Deep in the lungs, for example, cells called alveolar macrophages are constantly bombarded with inhaled chemicals, pathogens and particulates, and these cells play a crucial role in balancing immune responses while keeping inflammation at bay. However, molecules known as lipopolysaccharides, found in the membranes of certain bacteria, can lead to excessive inflammation, resulting in acute lung injury. The relationship between trained immunity and inflammation has so far remained unclear.</p><p>Now, in eLife, Maziar Divangahi of McGill University and colleagues – including Renaud Prével as first author – report more insights into the double-edged nature of trained immunity in the lungs (<xref ref-type="bibr" rid="bib9">Prével et al., 2024</xref>). The researchers investigated whether β-glucan can induce trained immunity in alveolar macrophages in mice, and how this affects acute lung injury.</p><p>Mice were injected with β-glucan and, seven days later, were treated with bacterial lipopolysaccharide or an immunostimulant called poly(I:C) to simulate viral infections. Mice that received bacterial lipopolysaccharide exhibited an increased number of neutrophils in the lungs. Furthermore, they developed elevated levels of several inflammatory chemical messengers, such as TNF-α, IL-6 and CXCL1, and displayed signs of acute lung injury (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Mice treated with the immunostimulant also demonstrated a rise in neutrophils and chemical messengers, apart from TNF-α, which remained unchanged.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Trained immunity and acute lung injury.</title><p>Injecting mice with β-glucan (Signal 1) resulted in trained immunity for alveolar macrophages (left panel). This trained immunity depended on neutrophils and type II interferon signalling (IFNγ). The macrophages remained in their trained state when transferred into mice that lacked immune cells (middle panel). Exposure to a secondary challenge (Signal 2) – such as a bacterial stimulus (LPS) or a viral stimulus (poly(I:C)) – later re-engaged the trained macrophages and induced a strong inflammatory response. This response includes neutrophil influx and increased production of several inflammatory chemical messengers (IL-6, CXCL1 and TNF- α), which led to acute lung injury (right panel). LPS: lipopolysaccharides; poly(I:C): polyinosinic:polycytidylic acid; AM: alveolar macrophage; IL-6: interleukin 6; CXCL1: chemokine (C-X-C motif) ligand 1; TNF-α: tumor necrosis factor alpha. This figure was created with <ext-link ext-link-type="uri" xlink:href="https://BioRender.com/nrhh7xt">BioRender.com</ext-link>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107787-fig1-v1.tif"/></fig><p>The work of Prével et al. is consistent with studies that have reported that β-glucan aggravates disease in models of periodontitis and arthritis (<xref ref-type="bibr" rid="bib3">Haacke et al., 2025</xref>). However, this contrasts with previous work, which showed that training with β-glucan can reduce lung fibrosis caused by exposure to the chemotherapy drug, bleomycin (<xref ref-type="bibr" rid="bib4">Kang et al., 2024</xref>). These conflicting findings emphasize the need to understand the contexts in which trained immunity may backfire.</p><p>Prével et al. – who are based at McGill University and institutes in Morocco and France – confirmed that alveolar macrophages are key mediators of the exaggerated immune response. Following β-glucan exposure, the number of immune cells in the lungs remained unchanged; however, the macrophages underwent metabolic and transcriptional reprogramming, which led to an increase in the production of inflammatory cytokines. This suggests that functional changes in the macrophages, rather than an increase in cell number, leads to stronger inflammation. Furthermore, transplanting trained alveolar macrophages into mice lacking these cells, followed by administration of lipopolysaccharide, initiated a heightened inflammatory response. This demonstrated that the phenotype is intrinsic to alveolar macrophages and independent of circulating monocytes.</p><p>Prével et al. also found that β-glucan training required type II interferon signaling but not type I. This contrasts with previous work showing a key role for the latter in lipopolysaccharide-trained alveolar macrophages exposed to pneumococcal bacteria (<xref ref-type="bibr" rid="bib12">Zahalka et al., 2022</xref>). Indeed, type II interferon signaling has also been implicated in training macrophages in response to bacterial, fungal and viral infections (<xref ref-type="bibr" rid="bib6">Leopold Wager et al., 2018</xref>; <xref ref-type="bibr" rid="bib10">Tran et al., 2024</xref>; <xref ref-type="bibr" rid="bib11">Wang et al., 2023</xref>; <xref ref-type="bibr" rid="bib1">Arafa et al., 2022</xref>).</p><p>Based on these results, Prével et al. go on to propose a framework in which the nature of the initial training signal (signal 1) and the nature of the secondary challenge (signal 2) determine the immunological outcome of trained immunity (<xref ref-type="fig" rid="fig1">Figure 1</xref>). This framework implies that trained immunity is not defined solely by the training signal, but also by the context in which the cells are re-engaged.</p><p>Other variables may also influence the outcomes of trained immunity, including differences in laboratory readouts (e.g., cytokines, tissue damage, microbial clearance) and routes of administration. For example, intravenous but not subcutaneous administration of the BCG vaccine enhanced antiviral responses of alveolar macrophages (<xref ref-type="bibr" rid="bib10">Tran et al., 2024</xref>).</p><p>Perhaps most importantly, the source and environment of the responding immune cells matter greatly. Much research has focused on blood-derived monocytes and their progenitors, including hematopoietic stem cells (<xref ref-type="bibr" rid="bib7">Moorlag et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Kaufmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib8">Netea et al., 2020</xref>). However, resident macrophages in tissues like the lung are increasingly recognized as key players in local trained immunity (<xref ref-type="bibr" rid="bib10">Tran et al., 2024</xref>; <xref ref-type="bibr" rid="bib12">Zahalka et al., 2022</xref>; <xref ref-type="bibr" rid="bib2">Chakraborty et al., 2023</xref>; <xref ref-type="bibr" rid="bib9">Prével et al., 2024</xref>). Moreover, neighboring immune cells can also shape trained immunity, as shown by the fact that neutrophils are required for the training of alveolar macrophages in the current study.</p><p>The study of Prével et al. is particularly compelling because, in addition to being found in the cell walls of bacteria, β-glucan is also a ubiquitous component of fungal cell walls, many of which reside within our microbiota. This raises the possibility that alveolar macrophages are constantly trained by our unique environments, lifestyles and even age.</p><p>The developmental history of alveolar macrophages adds another layer of complexity. Resident alveolar macrophages arise from fetal monocytes and self-renew, but during infection or injury, they can be replaced by monocyte-derived alveolar macrophages. These recruited cells are often more inflammatory, which helps to fight pathogens but also carries a higher risk of tissue damage. Future studies to assess how β-glucan training affects the development of the lung macrophage population will be of interest as well as the durability and molecular basis of the trained state.</p><p>Ultimately, the work of Prével et al. offers a nuanced view of trained immunity in an organ where immune restraint is often more important than immune reactivity. Understanding how trained immunity is shaped by training and cellular origin, signaling molecules, and the environment will be essential. As we continue to explore how innate immune memory is generated and maintained, one thing is clear: context is everything.</p></body><back><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arafa</surname><given-names>EI</given-names></name><name><surname>Shenoy</surname><given-names>AT</given-names></name><name><surname>Barker</surname><given-names>KA</given-names></name><name><surname>Etesami</surname><given-names>NS</given-names></name><name><surname>Martin</surname><given-names>IM</given-names></name><name><surname>Lyon De Ana</surname><given-names>C</given-names></name><name><surname>Na</surname><given-names>E</given-names></name><name><surname>Odom</surname><given-names>CV</given-names></name><name><surname>Goltry</surname><given-names>WN</given-names></name><name><surname>Korkmaz</surname><given-names>FT</given-names></name><name><surname>Wooten</surname><given-names>AK</given-names></name><name><surname>Belkina</surname><given-names>AC</given-names></name><name><surname>Guillon</surname><given-names>A</given-names></name><name><surname>Forsberg</surname><given-names>EC</given-names></name><name><surname>Jones</surname><given-names>MR</given-names></name><name><surname>Quinton</surname><given-names>LJ</given-names></name><name><surname>Mizgerd</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Recruitment and training of alveolar macrophages after pneumococcal pneumonia</article-title><source>JCI Insight</source><volume>7</volume><elocation-id>e150239</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.150239</pub-id><pub-id pub-id-type="pmid">35133985</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakraborty</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Sanborn</surname><given-names>MA</given-names></name><name><surname>Ye</surname><given-names>Z</given-names></name><name><surname>Maienschein-Cline</surname><given-names>M</given-names></name><name><surname>Mukhopadhyay</surname><given-names>A</given-names></name><name><surname>Ganesh</surname><given-names>BB</given-names></name><name><surname>Malik</surname><given-names>AB</given-names></name><name><surname>Rehman</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Trained immunity of alveolar macrophages enhances injury resolution via KLF4-MERTK-mediated efferocytosis</article-title><source>The Journal of Experimental Medicine</source><volume>220</volume><elocation-id>e20221388</elocation-id><pub-id pub-id-type="doi">10.1084/jem.20221388</pub-id><pub-id pub-id-type="pmid">37615937</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haacke</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>S</given-names></name><name><surname>Barovic</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Nagai</surname><given-names>K</given-names></name><name><surname>Botezatu</surname><given-names>A</given-names></name><name><surname>Hatzioannou</surname><given-names>A</given-names></name><name><surname>Gercken</surname><given-names>B</given-names></name><name><surname>Trimaglio</surname><given-names>G</given-names></name><name><surname>Shah</surname><given-names>AU</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Jaykar</surname><given-names>MT</given-names></name><name><surname>Rauner</surname><given-names>M</given-names></name><name><surname>Wielockx</surname><given-names>B</given-names></name><name><surname>Chung</surname><given-names>KJ</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Kalafati</surname><given-names>L</given-names></name><name><surname>Hajishengallis</surname><given-names>G</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Innate immune training of osteoclastogenesis promotes inflammatory bone loss in mice</article-title><source>Developmental Cell</source><elocation-id>S1534-5807(25)00063-2</elocation-id><pub-id pub-id-type="doi">10.1016/j.devcel.2025.02.001</pub-id><pub-id pub-id-type="pmid">40020679</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>YY</given-names></name><name><surname>Kim</surname><given-names>DY</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>T</given-names></name><name><surname>Cho</surname><given-names>JA</given-names></name><name><surname>Lee</surname><given-names>T</given-names></name><name><surname>Choi</surname><given-names>EY</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Innate immune training initiates efferocytosis to protect against lung injury</article-title><source>Advanced Science</source><volume>11</volume><elocation-id>e2308978</elocation-id><pub-id pub-id-type="doi">10.1002/advs.202308978</pub-id><pub-id pub-id-type="pmid">38279580</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>E</given-names></name><name><surname>Sanz</surname><given-names>J</given-names></name><name><surname>Dunn</surname><given-names>JL</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Mendonça</surname><given-names>LE</given-names></name><name><surname>Pacis</surname><given-names>A</given-names></name><name><surname>Tzelepis</surname><given-names>F</given-names></name><name><surname>Pernet</surname><given-names>E</given-names></name><name><surname>Dumaine</surname><given-names>A</given-names></name><name><surname>Grenier</surname><given-names>J-C</given-names></name><name><surname>Mailhot-Léonard</surname><given-names>F</given-names></name><name><surname>Ahmed</surname><given-names>E</given-names></name><name><surname>Belle</surname><given-names>J</given-names></name><name><surname>Besla</surname><given-names>R</given-names></name><name><surname>Mazer</surname><given-names>B</given-names></name><name><surname>King</surname><given-names>IL</given-names></name><name><surname>Nijnik</surname><given-names>A</given-names></name><name><surname>Robbins</surname><given-names>CS</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis</article-title><source>Cell</source><volume>172</volume><fpage>176</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.12.031</pub-id><pub-id pub-id-type="pmid">29328912</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leopold Wager</surname><given-names>CM</given-names></name><name><surname>Hole</surname><given-names>CR</given-names></name><name><surname>Campuzano</surname><given-names>A</given-names></name><name><surname>Castro-Lopez</surname><given-names>N</given-names></name><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Caballero Van Dyke</surname><given-names>MC</given-names></name><name><surname>Wozniak</surname><given-names>KL</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wormley</surname><given-names>FL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>IFN-γ immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans</article-title><source>PLOS Pathogens</source><volume>14</volume><elocation-id>e1007358</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007358</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moorlag</surname><given-names>S</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Novakovic</surname><given-names>B</given-names></name><name><surname>Kaufmann</surname><given-names>E</given-names></name><name><surname>Jansen</surname><given-names>T</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>β-Glucan induces protective trained immunity against <italic>Mycobacterium tuberculosis</italic> infection: A key role for IL-1</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107634</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107634</pub-id><pub-id pub-id-type="pmid">32433977</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Domínguez-Andrés</surname><given-names>J</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Mhlanga</surname><given-names>MM</given-names></name><name><surname>Mulder</surname><given-names>WJM</given-names></name><name><surname>Riksen</surname><given-names>NP</given-names></name><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>Stabell Benn</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>JC</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Defining trained immunity and its role in health and disease</article-title><source>Nature Reviews Immunology</source><volume>20</volume><fpage>375</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-0285-6</pub-id><pub-id pub-id-type="pmid">32132681</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prével</surname><given-names>R</given-names></name><name><surname>Pernet</surname><given-names>E</given-names></name><name><surname>Tran</surname><given-names>KA</given-names></name><name><surname>Sadek</surname><given-names>A</given-names></name><name><surname>Sadeghi</surname><given-names>M</given-names></name><name><surname>Lapshina</surname><given-names>E</given-names></name><name><surname>Jurado</surname><given-names>L</given-names></name><name><surname>Kristof</surname><given-names>AS</given-names></name><name><surname>Moumni</surname><given-names>M</given-names></name><name><surname>Poschmann</surname><given-names>J</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>β-glucan reprograms alveolar macrophages via neutrophil/IFNγ axis to promote lung injury</article-title><source>eLife</source><volume>13</volume><elocation-id>RP102068</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.102068</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>KA</given-names></name><name><surname>Pernet</surname><given-names>E</given-names></name><name><surname>Sadeghi</surname><given-names>M</given-names></name><name><surname>Downey</surname><given-names>J</given-names></name><name><surname>Chronopoulos</surname><given-names>J</given-names></name><name><surname>Lapshina</surname><given-names>E</given-names></name><name><surname>Tsai</surname><given-names>O</given-names></name><name><surname>Kaufmann</surname><given-names>E</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>BCG immunization induces CX3CR1<sup>hi</sup> effector memory T cells to provide cross-protection via IFN-γ-mediated trained immunity</article-title><source>Nature Immunology</source><volume>25</volume><fpage>418</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1038/s41590-023-01739-z</pub-id><pub-id pub-id-type="pmid">38225437</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Influenza-trained mucosal-resident alveolar macrophages confer long-term antitumor immunity in the lungs</article-title><source>Nature Immunology</source><volume>24</volume><fpage>423</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1038/s41590-023-01428-x</pub-id><pub-id pub-id-type="pmid">36807642</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zahalka</surname><given-names>S</given-names></name><name><surname>Starkl</surname><given-names>P</given-names></name><name><surname>Watzenboeck</surname><given-names>ML</given-names></name><name><surname>Farhat</surname><given-names>A</given-names></name><name><surname>Radhouani</surname><given-names>M</given-names></name><name><surname>Deckert</surname><given-names>F</given-names></name><name><surname>Hladik</surname><given-names>A</given-names></name><name><surname>Lakovits</surname><given-names>K</given-names></name><name><surname>Oberndorfer</surname><given-names>F</given-names></name><name><surname>Lassnig</surname><given-names>C</given-names></name><name><surname>Strobl</surname><given-names>B</given-names></name><name><surname>Klavins</surname><given-names>K</given-names></name><name><surname>Matsushita</surname><given-names>M</given-names></name><name><surname>Sanin</surname><given-names>DE</given-names></name><name><surname>Grzes</surname><given-names>KM</given-names></name><name><surname>Pearce</surname><given-names>EJ</given-names></name><name><surname>Gorki</surname><given-names>AD</given-names></name><name><surname>Knapp</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Trained immunity of alveolar macrophages requires metabolic rewiring and type 1 interferon signaling</article-title><source>Mucosal Immunology</source><volume>15</volume><fpage>896</fpage><lpage>907</lpage><pub-id pub-id-type="doi">10.1038/s41385-022-00528-5</pub-id><pub-id pub-id-type="pmid">35856089</pub-id></element-citation></ref></ref-list></back></article>